Trade
Torrent Pharmaceuticals share price
Moderate risk
You have to be logged in to add this to Watchlist.- ₹4,895.20(-0.03%)July 10, 2026 15:29:08 PM IST
- NSE
- BSE
- Vol : 1.00 M (NSE + BSE)Last 20 day avg : 560.16 K
Torrent Pharmaceuticals is trading -0.03% lower at Rs 4,895.20 as compared to its last closing price. Torrent Pharmaceuticals has been trading in the price range of 4,909.95 & 4,781.40. Torrent Pharmaceuticals has given 27.23% in this year & 5.08% in the last 5 days. Torrent Pharmaceuticals has TTM P/E ratio 66.02 as compared to the sector P/E of 26.80.There are 29 analysts who have initiated coverage on Torrent Pharmaceuticals. There are 8 analysts who have given it a strong buy rating & 11 analysts have given it a buy rating. 2 analysts have given the stock a sell rating.The company posted a net profit of 389.37 Crores in its last quarter.Listed peers of Torrent Pharmaceuticals include Lupin (-0.24%), Sun Pharmaceutical Industries (-0.19%), Divi's Laboratories (0.31%).The Mutual Fund holding in Torrent Pharmaceuticals was at 4.45% in 31 Mar 2026. The MF holding has decreased from the last quarter. The FII holding in Torrent Pharmaceuticals was at 16.18% in 31 Mar 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Key Metrics
Updated on Jul 11, 2026, 09:09 AM UTC
- BetaLow volatility0.54Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry1.79The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.78Annual dividends as a percentage of the stock price.
- P/EHigher than historical values76.63Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates overvaluation3.79The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Torrent Pharmaceuticals News
Torrent Pharmaceuticals Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Lupin | 2,496.90 | -0.24 | 1,14,166.98 | 28.78 | 5.59 | 0.57 | 11.80 |
| Sun Pharmaceutical Industries | 1,935.25 | -0.19 | 4,64,320.36 | 36.24 | 5.77 | 0.92 | 0.50 |
| Divi's Laboratories | 6,832.30 | 0.31 | 1,81,268.32 | 78.61 | 11.52 | 0.46 | 0.01 |
| Dr Reddy's Laboratories | 1,245.50 | -1.91 | 1,03,714.06 | 18.63 | 3.14 | 0.63 | 2.34 |
| Cipla | 1,438.75 | -0.20 | 1,16,228.75 | 22.95 | 3.87 | 0.87 | 0.81 |
Mutual Fund Ownership
View allTorrent Pharmaceuticals Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-05-22 | Audited Results, Dividend & Fund Raising |
| 2026-02-13 | Quarterly Results & Interim Dividend |
| 2026-01-05 | Others |
| 2025-11-07 | Quarterly Results |
| 2025-07-28 | Quarterly Results & Others |
About the company Torrent Pharmaceuticals
- IndustryBiotechnology & Drugs
- ISININE685A01028
- BSE Code500420
- NSE CodeTORNTPHARM
Torrent Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. The Company is focused on various therapeutic segments, such as cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), vitamins minerals nutrients (VMN), anti-diabetes (AD), pain management, gynecology, and dermatology. Its pediatric product brands include Tedibar, Atogla, Spoo and B4 Nappi. Its Anti-diabetic products include Gliclazide 80 mg, Tablets, Gliclazide 30 mg, Tablets, Glimepiride 1, 2, 3, 4 mg, Tablets, and others. Its dermatologic therapy products include Macrotor, Ahaglow S Facewash, Fungicide Lotion, Hairjoy 2%, New Dewsoft Cream, Lookbrite 20GMS, Cortaz NC, Dermanex, and others. Its manufacturing facilities are located in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim.
Torrent Pharmaceuticals Share Price FAQs
Torrent Pharmaceuticals is trading at 4895.20 as on Fri Jul 10 2026 09:59:08. This is -0.03% lower as compared to its previous closing price of 4896.65.
The market capitalization of Torrent Pharmaceuticals is 165669.16 Cr as on Fri Jul 10 2026 09:59:08.
The average broker rating on Torrent Pharmaceuticals is Buy. The breakup of analyst rating is given below -
- 8 analysts have given a strong buy rating
- 11 analysts have given a buy rating
- 8 analysts have given a hold rating
- 2 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Torrent Pharmaceuticals is 4948.95 whereas the 52 wk low is 3300.00
Torrent Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 66.02
- Sector P/E: 26.80
- Dividend Yield: 0.78%
- D/E ratio: 1.79
Torrent Pharmaceuticals reported a net profit of 2163.37 Cr in 2026.
The Mutual Fund Shareholding was 4.45% at the end of 31 Mar 2026.
Quick Links
EQUITY QUICK LINKS
Torrent Pharmaceuticals QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.